Encompass Health Financial Statements
Encompass Health Financial Overview
Encompass Health's market cap is currently ―. The company's EPS TTM is $3.91; its P/E ratio is 11.91; and it has a dividend yield of 2.00%. Encompass Health is scheduled to report earnings on April 27, 2022, and the estimated EPS forecast is $0.73. See an overview of income statement, balance sheet, and cash flow financials.
| Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 1.33B | $ 1.32B | $ 1.28B | $ 1.29B | $ 1.23B |
| Gross Profit | $ 1.28B | $ 1.26B | $ 1.23B | $ 1.24B | $ 1.18B |
| EBIT | $ 180.90M | $ 187.30M | $ 200.80M | $ 223.60M | $ 210.10M |
| EBITDA | $ 247.10M | $ 253.10M | $ 265.70M | $ 287.00M | $ 272.60M |
| Net Income Common Stockholders | $ 87.10M | $ 89.80M | $ 100.00M | $ 112.80M | $ 106.80M |
| Balance Sheet | |||||
| Cash, Cash Equivalents and Short-Term Investments | $ 54.80M | $ 73.20M | $ 94.20M | $ 94.80M | $ 223.90M |
| Total Assets | $ 6.94B | $ 6.86B | $ 6.72B | $ 6.61B | $ 6.54B |
| Total Debt | $ 3.40B | $ 3.43B | $ 3.46B | $ 3.54B | $ 3.57B |
| Net Debt | $ 3.35B | $ 3.36B | $ 3.36B | $ 3.44B | $ 3.34B |
| Total Liabilities | $ 4.45B | $ 4.47B | $ 4.43B | $ 4.40B | $ 4.47B |
| Stockholders Equity | $ 1.52B | $ 1.59B | $ 1.66B | $ 1.76B | $ 1.84B |
| Cash Flow | |||||
| Free Cash Flow | $ 103.70M | $ -78.10M | $ 51.00M | $ 132.00M | $ 59.70M |
| Operating Cash Flow | $ 218.90M | $ 123.80M | $ 177.60M | $ 255.90M | $ 158.50M |
| Investing Cash Flow | $ -123.10M | $ -220.70M | $ -124.00M | $ -226.00M | $ -95.60M |
| Financing Cash Flow | $ -60.90M | $ 42.30M | $ -18.50M | $ -186.40M | $ -77.50M |